Jim Cramer highlighted how Amazon has changed the way consumers shop.
Jim Cramer rattles off his take on caller favorite stocks, including professing his approval for Tech Data.
UBS initiates coverage on CVS Health with a buy rating.
Some of the names on the move ahead of the open.
Jim Cramer rattles off his take on caller favorite stocks, including this restaurant stock feeling the pain.
Jim Cramer sipped on stocks in San Francisco, offered his take on the market.
Todd Gordon of TradingAnalysis.com is betting against CVS.
As Wal-Mart moves along with price cuts and reaps the benefits of its pending acquisition of Jet.com, analysts expect the company's advantage to grow.
Jim Cramer eyes a healthcare stock that should remain in favor on Wall Street.
A one-time janitor and gas station attendant demonstrated that you can become a multimillionaire with a modest salary.
Brad Arthur, Black Rock Pharmacy co-owner, shares his take on the rising drug prices and the pharma supply chain.
CNBC’s Meg Tirrell reports the latest on Mylan prices and the drug price blame game.
Wall Street likes health care despite its vulnerability to political headwinds and underperformance this year.
To blame the healthcare system is what Mylan CEO Heather Bresch told CNBC today in explaining why the price of her company's EpiPen has seen price hikes of 400%. CNBC's Meg Tirrell breaks down the pharma supply chain system.
CNBC's Meg Tirrell reports on the Pharmaceutical Care Management Association's response to Mylan blaming "the middlemen" for its EpiPen price hike.
The "FMHR" traders; Sarat Sethi, Douglas C. Lane & Associates; and Stephanie Link, TIAA Global Asset Management, reveal their final trades, including CVS, Square and more.
Jim Cramer analyzed the winners and losers in retail for the quarter and discovered an interesting trend.
"It's going to take awhile for Target to turn this around," one analyst told CNBC.
Citing a "difficult" retail environment, Target lowers its guidance for the full year.
CVS Health's new "excluded" list includes medications used in treatment of patients with cancer, diabetes and hepatitis C.